Epididymo-orchitis
Epididymo-orchitis is an acute or chronic inflammatory condition affecting the epididymis and/or testis, representing th... MRCP, FRCS, PLAB exam preparation.
Clinical board
A visual summary of the highest-yield teaching signals on this page.
Urgent signals
Safety-critical features pulled from the topic metadata.
- Testicular torsion (must exclude in acute scrotum)
- Abscess formation requiring drainage
- Fournier's gangrene (necrotising fasciitis)
- Bilateral involvement
Exam focus
Current exam surfaces linked to this topic.
- MRCP, FRCS, PLAB
Editorial and exam context
Reviewed by MedVellum Editorial Team · MedVellum Medical Education Platform
Credentials: MBBS, MRCP, Board Certified
Epididymo-orchitis
1. Clinical Overview
Summary
Epididymo-orchitis is an acute or chronic inflammatory condition affecting the epididymis and/or testis, representing the most common cause of acute scrotal pain in adults. The pathogen spectrum is predominantly age-dependent: in sexually active men under 35 years, sexually transmitted organisms (Chlamydia trachomatis and Neisseria gonorrhoeae) account for the majority of cases, whilst in men over 35 years and those with urological abnormalities, enteric bacteria (particularly Escherichia coli) from urinary tract infections predominate. [1,2,3]
The clinical presentation typically features unilateral scrotal pain of gradual onset over hours to days, associated with scrotal swelling, tenderness, and often urinary or urethral symptoms. The critical clinical challenge lies in differentiating epididymo-orchitis from testicular torsion—a surgical emergency requiring intervention within 6 hours to preserve testicular viability. Colour Doppler ultrasound demonstrates increased vascular flow in epididymo-orchitis (versus decreased/absent flow in torsion), making it the investigation of choice when clinical differentiation is uncertain. [4,5]
Empirical antibiotic therapy is tailored to the likely organism: ceftriaxone 500mg IM once plus doxycycline 100mg BD for 10-14 days for sexually transmitted infection (STI)-related cases; or fluoroquinolones (ofloxacin 200mg BD or ciprofloxacin 500mg BD for 10-14 days) for enteric organisms. [6,7] Complications include abscess formation (5-10%), chronic pain, and rarely infertility in bilateral or severe cases. Partner notification and testing are essential for STI-related epididymo-orchitis.
Key Facts
- Definition: Inflammation of the epididymis with or without testicular involvement, usually infectious in origin
- Incidence: Approximately 600,000 cases annually in the United States; most common cause of acute scrotal pain in adults [8]
- Age-pathogen relationship:
- "Under 35 years: Chlamydia trachomatis (most common), Neisseria gonorrhoeae"
- "Over 35 years: E. coli (most common), Enterococcus, Pseudomonas, other uropathogens [1,2]"
- Critical differential diagnosis: Testicular torsion (surgical emergency with 6-hour salvage window)
- Diagnostic imaging: Colour Doppler ultrasound shows increased epididymal/testicular blood flow (sensitivity 70-90%, specificity 88-100% for excluding torsion) [4,5]
- First-line treatment:
- "STI-related: Ceftriaxone 500mg IM stat + doxycycline 100mg BD × 10-14 days"
- "Enteric: Fluoroquinolone × 10-14 days [6,7]"
- Molecular diagnostics: First-void urine nucleic acid amplification test (NAAT) is test of choice for Chlamydia/Gonorrhoea (sensitivity > 95%) [3]
Clinical Pearls
Age-Based Empirical Therapy: "Under 35 = STI, Over 35 = UTI": This rule guides initial antibiotic selection. Men under 35 (especially if sexually active) require STI cover with ceftriaxone plus doxycycline; men over 35 (or with urological risk factors) need enteric cover with fluoroquinolones. However, consider patient-specific factors: a 40-year-old with new sexual partner may need STI cover; a 25-year-old with bladder outflow obstruction may need enteric cover.
Prehn's Sign Has Poor Diagnostic Accuracy: Although taught as a classic sign (pain relief on elevating the testis suggests epididymitis rather than torsion), Prehn's sign has not been validated in rigorous studies and should NOT be used to exclude torsion. When torsion is suspected clinically, proceed to urgent imaging or surgical exploration regardless of Prehn's sign. [9]
Torsion Must Be Excluded First in Acute Scrotum: In any patient presenting with acute scrotal pain, especially with sudden onset, high-riding testis, or absent cremasteric reflex, testicular torsion must be the primary consideration. The TWIST score (Testicular Workup for Ischemia and Suspected Torsion) can aid risk stratification: score 0-2 suggests low risk (torsion unlikely), 3-4 intermediate risk, 5-7 high risk. [10]
Don't Miss Fournier's Gangrene: Scrotal erythema extending to perineum or anterior abdominal wall, skin crepitus, systemic toxicity, or rapidly progressive symptoms should raise suspicion for necrotising fasciitis (Fournier's gangrene)—a urological emergency requiring immediate surgical debridement and broad-spectrum antibiotics. Mortality ranges from 20-40% despite treatment. [11]
Bilateral Epididymo-orchitis Warrants Broader Differential: While epididymo-orchitis is usually unilateral, bilateral presentation should prompt consideration of systemic causes including tuberculosis (especially in endemic areas or immunocompromised patients), sarcoidosis, vasculitis, or viral infections (mumps in non-immunised patients). [12]
30% of Cases Remain Culture-Negative: Modern molecular diagnostics (NAAT) have improved detection rates, but approximately 30% of epididymo-orchitis cases have no identifiable pathogen despite comprehensive testing. This may represent non-infectious inflammation, undetected pathogens, or prior antibiotic exposure. [2]
Why This Matters Clinically
Epididymo-orchitis is a common urological presentation with significant diagnostic and therapeutic implications. The primary clinical imperative is to reliably differentiate it from testicular torsion, as misdiagnosis can result in testicular loss within 6-12 hours. Delayed or inadequate antibiotic treatment can lead to abscess formation requiring surgical drainage, chronic scrotal pain (affecting quality of life and requiring long-term analgesia), and rarely infertility from bilateral epididymal obstruction.
From a sexual health perspective, STI-related epididymo-orchitis represents a sentinel event requiring partner notification, contact tracing, and screening for concurrent STIs (including HIV and syphilis). Failure to identify and treat sexual contacts perpetuates transmission and places partners at risk of complications. In men with enteric organism infection, underlying urological pathology (prostatic hypertrophy, urethral stricture, neurogenic bladder) may require urological assessment and intervention to prevent recurrence.
2. Epidemiology
Incidence & Prevalence
Overall Burden:
- Annual incidence: Approximately 600,000 cases in the United States [8]
- Healthcare visits: One of the commonest reasons for emergency department and urology clinic attendance for scrotal complaints
- Age-specific incidence: Bimodal distribution with peaks in sexually active young adults (15-35 years) and older men with prostatic/urological disease (> 50 years)
Temporal Trends:
- Rising incidence of STI-related epididymo-orchitis in some populations, paralleling increasing Chlamydia trachomatis prevalence [1]
- Declining incidence of mumps orchitis in countries with comprehensive MMR vaccination programmes
- Increasing recognition through improved molecular diagnostics (NAAT testing) [3]
Demographics
| Factor | Details |
|---|---|
| Age (STI-related) | Peak 15-35 years; median age approximately 25 years |
| Age (enteric) | Peak > 35 years; median age 50-60 years; often associated with BPH |
| Sex | Exclusively male (though analogous infections occur in females as PID) |
| Geography | Worldwide distribution; STI rates vary by region and population |
| Socioeconomic | STI-related cases more common in areas with higher STI prevalence; TB epididymitis in endemic regions |
| Sexual orientation | Men who have sex with men (MSM) at increased risk for STI-related disease; enteric organisms from insertive anal intercourse |
Risk Factors
Non-Modifiable:
- Male sex
- Age (determines organism spectrum)
- Anatomical urogenital abnormalities (ectopic ureter, urethral duplication)
Modifiable Behavioural:
| Risk Factor | Relative Risk | Comment |
|---|---|---|
| Multiple sexual partners | 2.5-4.0× | Increases STI exposure risk [1] |
| Unprotected sexual intercourse | 2.0-3.5× | Condom use significantly protective |
| New sexual partner (within 60 days) | 3.0× | Associated with acute STI acquisition |
| Previous STI history | 2.0× | Reflects ongoing exposure risk |
| Men who have sex with men | 1.5-2.5× | Higher STI prevalence; enteric organisms from anal sex |
Modifiable Medical:
| Risk Factor | Relative Risk | Mechanism |
|---|---|---|
| Benign prostatic hyperplasia (BPH) | 2.0-3.0× | Urinary stasis; bacteriuria; instrumentation |
| Indwelling urinary catheter | 2.5-4.0× | Biofilm formation; ascending infection |
| Urological instrumentation | 2.0-3.0× | Direct inoculation; mucosal trauma |
| Urethral stricture | 2.0× | Stasis; incomplete emptying |
| Neurogenic bladder | 1.5-2.5× | Incomplete emptying; recurrent UTI |
| Immunosuppression | Variable | Opportunistic organisms (TB, fungi); severe disease |
| Structural renal abnormalities | 1.5-2.0× | Reflux; recurrent UTI |
Iatrogenic:
- Post-prostatectomy (TURP, open, robotic): Bacteriuria and instrumentation
- Post-vasectomy (rare): Sperm granuloma mimicking epididymitis
- Amiodarone use: Non-infectious chemical epididymitis (rare adverse effect)
3. Pathophysiology
Molecular Pathophysiology
Step 1: Pathogen Entry and Ascent
Sexually Transmitted Organisms (STI Pathway):
- Chlamydia trachomatis (serovars D-K) and Neisseria gonorrhoeae infect urethral epithelial cells
- C. trachomatis: Obligate intracellular bacterium; infects columnar epithelium via elementary body attachment and invasion
- N. gonorrhoeae: Gram-negative diplococci; utilise pili and outer membrane proteins (Opa, Opc) for epithelial adherence and invasion
- Organisms ascend retrogradely from the posterior urethra through the ejaculatory duct and vas deferens to reach the epididymis
- Ascent promoted by: Sexual activity, urethral trauma, incomplete treatment of urethritis [1,3]
Enteric Organisms (UTI Pathway):
- E. coli, Enterococcus spp., Pseudomonas aeruginosa, Proteus mirabilis colonise the lower urinary tract
- Infection typically originates from bladder bacteriuria (cystitis) or prostatitis
- Retrograde flow of infected urine into the ejaculatory ducts occurs during micturition or prostatic massage
- Contributing factors: Bladder outflow obstruction (BPH), high-pressure voiding, vesico-ejaculatory reflux [2]
Haematogenous Spread (Rare):
- Viral infections: Mumps virus (paramyxovirus) causes orchitis via viremia; typically occurs 4-8 days after parotitis in 20-30% of post-pubertal males [12]
- Tuberculosis: Mycobacterium tuberculosis spreads haematogenously from primary pulmonary focus to epididymis/testis; presents as chronic granulomatous inflammation
- Brucellosis, syphilis (rarely): Haematogenous dissemination to genital tract
Step 2: Epididymal Infection and Inflammation
- Pathogens initially infect the epididymis (epididymitis), typically beginning in the cauda (tail) and ascending to the corpus and caput (head)
- Bacterial adherence to epididymal epithelium triggers innate immune response:
- Pattern recognition receptors (TLRs, particularly TLR2/4) recognise bacterial PAMPs (pathogen-associated molecular patterns)
- Activation of NF-κB pathway → pro-inflammatory cytokine release (IL-1β, IL-6, IL-8, TNF-α)
- Neutrophil chemotaxis and transmigration into epididymal tubules
- Acute inflammatory response causes:
- Vascular congestion and increased capillary permeability (erythema, oedema)
- Neutrophil infiltration with formation of microabscesses in severe cases
- Tubular epithelial damage and shedding
Step 3: Extension to Testis (Orchitis)
- In approximately 40-60% of cases, inflammation extends from epididymis to adjacent testis (epididymo-orchitis)
- Mechanisms: Direct spread through tunica vaginalis; shared lymphatic drainage; vascular congestion
- Testicular inflammation characterised by:
- Interstitial oedema separating seminiferous tubules
- Inflammatory infiltrate (neutrophils in acute; lymphocytes/macrophages in chronic)
- Potential damage to spermatogenic epithelium and Leydig cells
Step 4: Vascular Changes (Doppler Findings)
- Acute inflammation → marked increase in epididymal and testicular arterial blood flow
- Mechanisms: Inflammatory mediators (prostanoids, nitric oxide) cause vasodilatation; angiogenesis via VEGF upregulation
- Doppler ultrasound findings: Increased arterial flow with low-resistance waveforms; diffuse hypervascularity
- Contrast with testicular torsion: Absent/decreased arterial flow due to spermatic cord twisting and vascular occlusion [4,5]
Step 5: Complications (If Untreated or Severe)
Abscess Formation (5-10% of cases):
- Coalescence of microabscesses → macroscopic abscess cavity
- Liquefactive necrosis with purulent collection
- Clinical features: Persistent fever despite antibiotics, fluctuant scrotal mass, systemic toxicity
- Requires surgical drainage
Testicular Infarction (Rare):
- Severe oedema and inflammation → increased intra-scrotal pressure
- Compression of testicular blood supply (venous outflow obstruction initially, arterial compromise if severe)
- Results in segmental or complete testicular infarction
- Mimics torsion on imaging (absent flow); may require surgical exploration
Chronic Epididymitis:
- Persistent low-grade inflammation beyond 6 weeks
- Aetiology often unclear: Incompletely treated infection, autoimmune, obstructive, idiopathic
- Histology: Chronic inflammatory infiltrate (lymphocytes, plasma cells), fibrosis, tubular atrophy
- Clinical: Chronic scrotal discomfort, thickened epididymis, resistant to antibiotics
Infertility and Obstruction:
- Bilateral severe epididymitis → epididymal tubule obstruction from scarring and fibrosis
- Results in obstructive azoospermia (spermatogenesis normal but sperm transport blocked)
- Unilateral cases rarely cause infertility unless pre-existing contralateral dysfunction
- Post-infectious antisperm antibody formation may contribute to subfertility
Classification
By Duration:
| Type | Definition | Typical Features |
|---|---|---|
| Acute epididymitis | Symptoms less than 6 weeks | Sudden onset pain, swelling, fever; bacterial aetiology |
| Subacute epididymitis | Symptoms 6-12 weeks | Less pronounced inflammation; incomplete treatment |
| Chronic epididymitis | Symptoms > 3 months | Dull aching pain; minimal/no fever; often non-infectious |
By Organism:
| Category | Organisms | Typical Population | Notes |
|---|---|---|---|
| Sexually transmitted | C. trachomatis, N. gonorrhoeae | Men less than 35 years; sexually active | Requires partner notification |
| Enteric (uropathogenic) | E. coli, Enterococcus, Pseudomonas, Proteus | Men > 35 years; urological disease | Associated with UTI, BPH |
| Viral | Mumps virus (paramyxovirus) | Unvaccinated post-pubertal males | 20-30% develop orchitis after parotitis [12] |
| Granulomatous | M. tuberculosis, Brucella, fungi | TB-endemic areas; immunocompromised | Chronic "cold abscess"; needs AFB/culture |
| Culture-negative | No organism identified | 20-30% of all cases [2] | May reflect prior antibiotics, non-infectious, or undetected pathogens |
By Anatomical Extent:
| Type | Involvement | Clinical Distinction |
|---|---|---|
| Isolated epididymitis | Epididymis only | Tenderness posterior/lateral to testis; testis normal size |
| Epididymo-orchitis | Epididymis + testis | Entire hemiscrotum enlarged and tender; difficult to separate structures |
| Isolated orchitis | Testis only (rare) | Viral (mumps), granulomatous (TB, sarcoid), autoimmune; no urethritis |
Anatomical Considerations
Epididymal Anatomy:
- The epididymis is a 6-7 meter long, tightly coiled tubule lying posterior and lateral to the testis
- Divided into: Caput (head, superior), corpus (body), cauda (tail, inferior)
- Function: Sperm maturation and storage; 12-day transit time from caput to cauda
- Infection typically begins in cauda (closest to vas deferens) and ascends
Vas Deferens and Ejaculatory Duct:
- Vas deferens connects cauda epididymis to ejaculatory duct (within prostate)
- Provides pathway for retrograde bacterial ascent from urethra/bladder to epididymis
- Vasectomy interrupts this pathway (hence post-vasectomy epididymitis is rare)
Blood Supply:
- Testis: Testicular artery (from aorta); venous drainage via pampiniform plexus
- Epididymis: Branches from testicular artery plus artery of vas deferens
- Shared blood supply explains why severe epididymal inflammation can compromise testicular perfusion
Cremasteric Reflex:
- Stroking medial thigh → cremasteric muscle contraction → testicular elevation
- Reflex arc: Ilioinguinal nerve (L1) afferent; genitofemoral nerve (L1-L2) efferent
- Present in epididymo-orchitis (inflammation does not affect reflex)
- Absent in testicular torsion (sensitivity 99%, but only tested reliably pre-puberty to young adulthood; unreliable in very young and older adults) [10]
4. Clinical Presentation
Symptoms
Cardinal Symptoms:
| Symptom | Prevalence | Characteristics | Differentiating Features |
|---|---|---|---|
| Unilateral scrotal pain | 95-100% | Gradual onset over hours to days; progressively worsening | Torsion: sudden onset, maximal pain at outset |
| Scrotal swelling | 90-95% | Hemiscrotum enlarged; may develop reactive hydrocele | Diffuse; entire epididymis ± testis involved |
| Scrotal tenderness | 95-100% | Maximal tenderness over epididymis (posterior-lateral) | Initially localized, then diffuse if orchitis develops |
Associated Urogenital Symptoms:
| Symptom | Prevalence | Significance |
|---|---|---|
| Dysuria | 30-50% | Suggests concurrent urethritis or cystitis; more common in enteric infections |
| Urinary frequency | 25-40% | Cystitis or prostatitis; enteric organisms |
| Urethral discharge | 20-35% | Highly suggestive of STI (gonorrhoea/chlamydia); purulent (GC) vs mucoid (chlamydia) |
| Haematuria | 5-10% | Severe urethritis/cystitis; consider alternative diagnoses (stone, tumour) |
| Urinary retention | less than 5% | Severe prostatitis; abscess compressing urethra; requires catheterisation |
Systemic Symptoms:
| Symptom | Prevalence | Significance |
|---|---|---|
| Fever | 30-60% | Low-grade (less than 38.5°C) common; high fever (> 39°C) suggests abscess or systemic spread |
| Rigors | 5-10% | Concerning for bacteraemia; consider admission for IV antibiotics |
| Nausea/vomiting | 10-20% | Vagal response to severe pain; also seen in torsion (TWIST score component) [10] |
| Malaise | 30-50% | Non-specific systemic inflammatory response |
Atypical Presentations:
- Chronic indolent pain (chronic epididymitis): Dull ache > 3 months; minimal fever; recurrent or persistent; may be non-infectious
- Bilateral involvement: Rare (less than 5%); consider systemic causes (TB, sarcoidosis, vasculitis, mumps)
- Painless scrotal mass: Consider tumour, chronic epididymitis, granulomatous disease; always exclude malignancy
- Recurrent episodes: Structural urological abnormality (stricture, BPH, stone), chronic prostatitis, inadequate initial treatment
Signs
Scrotal Examination Findings:
| Sign | Description | Clinical Significance |
|---|---|---|
| Tender, enlarged epididymis | Palpable thickening posterior-lateral to testis | Initially, epididymis distinguishable from testis; classic finding |
| Testicular tenderness/swelling | Testis itself tender and enlarged | Indicates orchitis component (epididymo-orchitis); harder to distinguish from epididymis |
| Scrotal erythema | Hemiscrotum red, warm | Acute inflammation; if extending to perineum/abdominal wall → Fournier's? |
| Scrotal oedema | Thickened, pitting scrotal skin | Reactive to underlying inflammation |
| Reactive hydrocele | Transilluminable fluid collection | Inflammatory exudate; may obscure palpation of underlying structures |
| Thickened spermatic cord | Palpable fullness in inguinal canal | Funiculitis (inflammation extending along vas deferens) |
| Cremasteric reflex PRESENT | Testis elevates when inner thigh stroked | Helpful to exclude torsion if reliably present (see limitations below) |
| Normal testicular lie | Testis in normal longitudinal orientation | Torsion: high-riding, horizontally oriented testis |
Urethral Examination:
| Finding | STI Probability | Action |
|---|---|---|
| Purulent urethral discharge | High (gonorrhoea likely) | Urethral swab NAAT; also first-void urine NAAT |
| Mucoid discharge | Moderate (chlamydia) | NAAT testing |
| No discharge | Does not exclude STI | First-void urine NAAT still required |
Abdominal/Systemic Signs:
- Lower abdominal tenderness: Referred pain from epididymis; or concurrent prostatitis/cystitis
- Suprapubic tenderness: Cystitis, urinary retention (palpable bladder)
- Prostatic tenderness on DRE: Concurrent prostatitis (enteric organisms); boggy, tender prostate
- Fever and tachycardia: Systemic inflammatory response; fever > 39°C or rigors → consider abscess or sepsis
Red Flags — Urgent Action Required
[!CAUTION] RED FLAGS requiring immediate escalation:
Testicular Torsion Indicators (SURGICAL EMERGENCY — 6-hour window):
- Sudden onset severe pain (maximal at onset, not progressively worsening)
- High-riding testis with abnormal (horizontal) lie
- Absent cremasteric reflex (especially in adolescents/young adults)
- TWIST score ≥5 (high probability torsion) [10]
- Action: Urgent urology referral; do NOT delay for imaging if high clinical suspicion
Fournier's Gangrene (Necrotising Fasciitis — SURGICAL EMERGENCY):
- Rapidly progressive scrotal pain and swelling (hours)
- Skin erythema extending beyond scrotum to perineum, anterior abdominal wall, thighs
- Skin crepitus (subcutaneous gas)
- Skin necrosis, bullae, or ecchymosis
- Systemic toxicity (fever, tachycardia, hypotension)
- Action: Immediate surgical debridement + broad-spectrum antibiotics + ICU; mortality 20-40% [11]
Abscess Indicators:
- Persistent fever (> 48 hours) despite appropriate antibiotics
- Fluctuant scrotal mass
- Increasing pain and swelling on treatment
- Action: Imaging (ultrasound); surgical drainage if confirmed
Sepsis Indicators:
- Fever > 39°C with rigors
- Tachycardia (> 100 bpm), tachypnoea (> 20/min), hypotension
- Confusion, reduced urine output
- Action: Sepsis 6 protocol; blood cultures; IV antibiotics; consider admission
Clinical Decision Tools:
TWIST Score (Testicular Workup for Ischemia and Suspected Torsion): [10]
| Parameter | Points |
|---|---|
| Testicular swelling | 2 |
| Hard testis | 2 |
| Absent cremasteric reflex | 1 |
| Nausea/vomiting | 1 |
| High-riding testis | 1 |
| Total | /7 |
Interpretation:
- 0-2 points: Low probability (less than 10%) — Torsion unlikely; epididymo-orchitis likely; may observe or image
- 3-4 points: Intermediate probability (30-50%) — Imaging (Doppler ultrasound) mandatory
- 5-7 points: High probability (> 80%) — Torsion likely; urgent surgical exploration (do not delay for imaging if surgeon available)
Sensitivity: 100% (score ≥5 for torsion); Specificity: 75% (score ≤2 excludes torsion)
5. Clinical Examination
Structured Approach
1. General Assessment
- Vital signs: Temperature (fever?), pulse (tachycardia?), BP (hypotension suggests sepsis)
- General appearance: Distressed? Systemically unwell? Walking posture (gentle gait suggests severe pain)
2. Abdominal Examination
- Inspection: Distension, surgical scars
- Palpation: Suprapubic tenderness (cystitis, retention), lower abdominal tenderness (referred pain)
- Percussion: Dullness over distended bladder (retention)
- Palpate kidneys: Renal angle tenderness (pyelonephritis, perinephric abscess — rare associations)
3. External Genitalia — Scrotal Examination (Patient Supine)
Inspection:
- Symmetry: Hemiscrotum enlarged? Which side?
- Skin changes: Erythema (inflammation), oedema (pitting?), ecchymosis (trauma, torsion), necrosis or crepitus (Fournier's)
- Testicular lie: Normal longitudinal vs high-riding horizontal (torsion)
Palpation (Gentle Bimanual Technique):
- Testis: Size (normal, enlarged?), consistency (normal, hard, tender?), position (normal vs high-riding)
- Epididymis: Locate posterolaterally; thickened? Tender? Can you distinguish it from testis? (Early: yes; late: no)
- Spermatic cord: Palpate from testis to external inguinal ring; thickened (funiculitis)?
- Hydrocele: Fluid wave? (Reactive hydrocele common in epididymo-orchitis)
Transillumination:
- Shine light through scrotum in darkened room
- Positive (light transmits): Hydrocele, spermatocele
- Negative (no light transmission): Solid mass (tumour, haematocele), thick inflammatory exudate
4. Cremasteric Reflex
- Technique: Stroke inner thigh (medial to lateral) with blunt object; observe ipsilateral testis
- Normal: Testis elevates briskly
- Absent: Suggests torsion (but unreliable in neonates and older adults)
- Present: Makes torsion less likely (though does not exclude it entirely; if clinical suspicion remains high, image)
5. Prehn's Sign (Historical — NOT Recommended for Clinical Decision-Making)
- Technique: Gently elevate testis to reduce tension on spermatic cord
- Classical teaching: Pain relief suggests epididymitis; pain worsens suggests torsion
- Reality: Poor sensitivity and specificity; NOT validated; DO NOT rely on this sign [9]
6. Urethral Examination
- Inspect meatus: Discharge? (Purulent = gonorrhoea likely; mucoid = chlamydia)
- Milk urethra: Gently compress penis from base to meatus to express discharge
- If discharge present: Obtain urethral swab for NAAT (or rely on first-void urine NAAT)
7. Digital Rectal Examination (DRE) — If Indicated
- Indications: Age > 35, urinary symptoms, suspected prostatitis
- Findings:
- "Tender, boggy prostate: Acute prostatitis (associated with epididymo-orchitis in enteric infections)"
- "Enlarged, smooth prostate: BPH (risk factor for epididymo-orchitis)"
- "Hard, irregular prostate: Prostate cancer (unrelated, but important finding)"
Examination Red Flags
| Finding | Differential Diagnosis | Urgency |
|---|---|---|
| Sudden severe pain, high-riding testis, absent cremasteric reflex | Testicular torsion | IMMEDIATE surgical referral |
| Crepitus, skin necrosis, extending erythema | Fournier's gangrene | IMMEDIATE surgical debridement |
| Hard, non-tender testicular mass | Testicular tumour | Urgent urology (tumour does not present acutely, but may be incidental finding) |
| Bilateral involvement in adolescent | Mumps orchitis (if unvaccinated), autoimmune | Serology; exclude other causes |
| Chronic painless epididymal mass | TB epididymitis, tumour | Imaging; AFB cultures; biopsy |
6. Investigations
Bedside Tests
| Test | Findings | Interpretation | Notes |
|---|---|---|---|
| Urinalysis (dipstick) | Leucocytes +, Nitrites + | Suggests UTI (enteric organisms) | May be negative in STI (no pyuria) |
| Leucocytes +, Nitrites − | Sterile pyuria: STI, TB, recent antibiotics | Send NAAT and culture | |
| Blood + | Cystitis, urethritis, stone, tumour | Further imaging if persistent | |
| Vital signs | Fever > 38.5°C | Systemic infection; consider IV antibiotics | Fever > 39°C with rigors → abscess or sepsis |
| Tachycardia, hypotension | Sepsis, hypovolaemia | Sepsis 6 protocol |
Laboratory Investigations
Microbiological Tests (FIRST-LINE):
| Test | Indication | Expected Findings | Sensitivity/Specificity | Notes |
|---|---|---|---|---|
| First-void urine NAAT (Chlamydia/Gonorrhoea) | ALL patients less than 35 years; or STI risk factors | Positive for C. trachomatis or N. gonorrhoeae | Sensitivity > 95%, Specificity > 99% [3] | GOLD STANDARD for STI detection; first 10-20ml of voided urine (not midstream) |
| Mid-stream urine (MSU) culture & sensitivity | ALL patients > 35 years; or UTI symptoms | Growth of E. coli, Enterococcus, Pseudomonas | Sensitivity 80-90% | Guides antibiotic choice; obtain before antibiotics if possible |
| Urethral swab NAAT | Urethral discharge present | As above | As above | Alternative to urine NAAT; similar sensitivity |
| Blood cultures | Fever > 38.5°C, rigors, sepsis | May be positive in bacteraemia | Positive in less than 10% | Two sets from different sites |
Inflammatory Markers:
| Test | Typical Findings | Utility | Limitations |
|---|---|---|---|
| C-reactive protein (CRP) | Elevated (50-200 mg/L in moderate; > 200 in severe/abscess) | Marker of inflammation; trends helpful to monitor response | Non-specific; doesn't distinguish epididymitis from torsion |
| White cell count (WCC) | Leucocytosis (12-20 × 10⁹/L); neutrophilia | Suggests bacterial infection | Normal WCC does not exclude infection |
| Procalcitonin | Elevated in bacterial infection (if checked) | Distinguishes bacterial from viral; rarely needed in epididymitis | Expensive; not routinely required |
Additional Tests in Specific Scenarios:
| Scenario | Test | Purpose |
|---|---|---|
| Bilateral/chronic epididymitis in endemic area or immigrant | Sputum/urine AFB culture, GeneXpert MTB/RIF | Exclude tuberculosis |
| Post-pubertal male with parotitis | Mumps IgM/IgG serology; viral PCR | Confirm mumps orchitis [12] |
| Unexplained chronic epididymitis, systemic symptoms | ACE level, CXR, biopsy | Exclude sarcoidosis (granulomatous orchitis) |
| Travel to endemic areas | Brucella serology, blood cultures | Brucellosis (Middle East, Mediterranean) |
| All STI-related cases | Syphilis serology, HIV test | Screen for concurrent STIs |
Imaging
Scrotal Colour Doppler Ultrasound:
| Indication | Findings in Epididymo-orchitis | Findings in Torsion | Sensitivity/Specificity |
|---|---|---|---|
| When diagnosis uncertain | • Enlarged, hypoechoic epididymis • Increased blood flow on Doppler (hypervascularity) • Reactive hydrocele • Thickened scrotal skin | • Normal/enlarged testis (early) • Absent/decreased arterial flow • "Whirlpool sign" of twisted cord [13] | Sensitivity 70-90% for torsion exclusion; Specificity 88-100% [4,5] |
| Abscess suspected | Heterogeneous collection with fluid-debris level; increased peripheral vascularity | N/A | Sensitivity ~95% for abscess |
| Chronic/recurrent epididymitis | Thickened, heterogeneous epididymis; calcifications (TB); mass (tumour) | N/A | Excludes structural causes |
Ultrasound Pitfalls:
- False negatives for torsion: Intermittent torsion (spontaneous detorsion); partial torsion (some flow preserved)
- False positives (mimicking orchitis): Torsion-detorsion may show hyperaemia
- Operator-dependent: Sensitivity varies with operator experience and equipment quality
- Do NOT delay surgery for imaging if high clinical suspicion (TWIST ≥5) and surgeon immediately available
CT or MRI:
| Indication | Modality | Findings |
|---|---|---|
| Suspected Fournier's gangrene | CT pelvis with IV contrast | Gas in soft tissues (pathognomonic); fascial thickening; abscess |
| Retroperitoneal extension suspected | CT abdomen/pelvis | Fluid collections; abscess tracking along spermatic cord |
| Testicular tumour cannot be excluded | MRI scrotum (if ultrasound equivocal) | Characterises solid vs cystic masses; distinguishes inflammation from neoplasm |
Diagnostic Criteria
Clinical Diagnosis of Acute Epididymo-orchitis (Requires):
- Unilateral scrotal pain and tenderness (gradual onset over hours to days)
- AND palpable epididymal tenderness/swelling
- AND exclusion of testicular torsion (clinically or by imaging)
- PLUS supportive features:
- Urinary symptoms (dysuria, frequency) OR urethral discharge
- Fever (30-60% of cases)
- Positive microbiological tests (NAAT or culture)
- Doppler ultrasound showing increased epididymal flow
Diagnostic Certainty Levels:
| Level | Criteria | Confidence |
|---|---|---|
| Definite | Clinical features + positive NAAT or culture + Doppler confirmation | High |
| Probable | Clinical features + positive microbiology (no imaging) | Moderate-High |
| Possible | Clinical features alone; negative microbiology; no imaging | Moderate (30% culture-negative [2]) |
| Unlikely | TWIST score ≥5; sudden onset; absent cremasteric reflex → Torsion more likely | Low for epididymitis |
7. Management
Management Algorithm
ACUTE SCROTAL PAIN
↓
[Clinical Assessment + TWIST Score]
↓
┌───────────────────────────────┐
↓ ↓
TWIST ≥5 OR High Clinical TWIST ≤4 AND Gradual Onset
Suspicion for Torsion Epididymitis Features
↓ ↓
URGENT SURGICAL [Doppler Ultrasound if uncertain]
EXPLORATION ↓
(Do NOT delay for ┌─────────────┐
imaging if surgeon ↓ ↓
available) Increased Absent/Decreased
Flow Flow
↓ ↓
EPIDIDYMO-ORCHITIS TESTICULAR TORSION
↓ (Urgent Surgery)
[Microbiological Tests]
↓
┌────────────────────┐
↓ ↓
Age less than 35 OR Age ≥35 OR
STI Risk UTI Risk
↓ ↓
• Urine NAAT • Urine culture
(Chlamydia/GC) (Enteric organisms)
↓ ↓
[Empirical Antibiotics While Awaiting Results]
↓ ↓
CEFTRIAXONE 500mg IM FLUOROQUINOLONE
(Single dose) (Ofloxacin 200mg BD
+ OR Ciprofloxacin 500mg BD)
DOXYCYCLINE 100mg BD × 10-14 days
× 10-14 days
↓ ↓
[Supportive Measures: Rest, Scrotal Support, Analgesia]
↓
[Review at 48-72 hours]
↓
┌─────────────────────┐
↓ ↓
Improving Not Improving
↓ ↓
Complete Course • Check compliance
Partner Notification • Repeat imaging (abscess?)
(if STI) • Consider admission
• Alternative diagnosis?
Conservative Management (Adjunctive for All Patients)
| Intervention | Details | Evidence/Rationale |
|---|---|---|
| Bed rest | During acute phase (first 3-5 days) | Reduces movement-related pain; promotes resolution |
| Scrotal support | Supportive underwear (snug briefs) or athletic support | Reduces tension on spermatic cord; may provide symptomatic relief |
| Ice packs | Wrapped in cloth; 20 minutes on, 20 minutes off | Reduces inflammation and oedema; analgesic effect |
| Scrotal elevation | Lie supine with pillow under scrotum | Reduces venous congestion; symptom relief |
| Analgesia | • NSAIDs: Ibuprofen 400mg TDS or Naproxen 500mg BD • Paracetamol 1g QDS • Avoid opioids unless severe | NSAIDs: Anti-inflammatory + analgesic; superior to paracetamol alone |
| Avoid sexual activity | Until symptoms resolve | Prevents symptom exacerbation; reduces transmission risk (if STI) |
| Adequate hydration | Encourage oral fluids | Maintains urine output (flushes urinary tract if enteric infection) |
Medical Management — Antibiotic Regimens
STI-Related Epididymo-orchitis (Age less than 35 OR Sexual Risk Factors): [6,7]
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Ceftriaxone | 500mg (or 1g if > 150kg) | IM (deltoid or gluteal) | Single dose | Covers gonorrhoea (including resistant strains); pregnancy-safe |
| PLUS | ||||
| Doxycycline | 100mg | Oral (BD) | 10-14 days | Covers chlamydia; achieves therapeutic levels in genital tract; CONTRAINDICATED in pregnancy |
Alternative Regimens (If Ceftriaxone/Doxycycline Not Suitable):
| Scenario | Alternative | Notes |
|---|---|---|
| Ceftriaxone allergy | Gentamicin 240mg IM stat | Less evidence; ensure no renal impairment |
| Doxycycline contraindicated (pregnancy, allergy) | Azithromycin 1g oral stat, then 500mg OD for 2 days | Less effective for chlamydia than doxycycline; use only if no alternative |
| Severe penicillin/cephalosporin allergy | Azithromycin 2g oral stat (for GC) + Ofloxacin 200mg BD × 14 days | Check local gonorrhoea resistance patterns (quinolone resistance common) |
Enteric Organism Epididymo-orchitis (Age ≥35 OR Urological Risk Factors): [6,7]
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Ofloxacin (First-line) | 200mg BD | Oral | 14 days | Excellent genital tract penetration; broad gram-negative cover |
| OR | ||||
| Ciprofloxacin | 500mg BD | Oral | 10-14 days | Alternative fluoroquinolone; lower genital tract levels than ofloxacin |
| OR | ||||
| Levofloxacin | 500mg OD | Oral | 10 days | Once-daily dosing; similar efficacy |
Fluoroquinolone Contraindications/Cautions:
- Avoid: Pregnancy, breastfeeding, children (less than 18 years), severe renal impairment (eGFR less than 20)
- Cautions: Tendinopathy risk (especially > 60 years, concurrent steroids); QT prolongation; seizure history
- Resistance: Check local antibiogram; E. coli quinolone resistance rates vary (10-30% in many areas)
Alternative if Fluoroquinolones Contraindicated:
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Co-trimoxazole | 960mg BD | Oral | 14 days | If organism known sensitive; avoid if sulfa allergy or G6PD deficiency |
| Cephalexin | 500mg QDS | Oral | 14 days | Narrow spectrum; less effective for Pseudomonas; not first-line |
Severe/Complicated Epididymo-orchitis (Requiring Admission):
| Indication for Admission | IV Regimen | Duration | Notes |
|---|---|---|---|
| • Sepsis (qSOFA ≥2) • Unable to tolerate oral • Abscess formation • Diagnostic uncertainty | Ceftriaxone 2g IV OD OR Cefotaxime 1g IV TDS ± Gentamicin 5-7mg/kg IV OD (if severe sepsis) | Until afebrile + clinically improving (48-72h), then switch to oral to complete 14 days | Broad-spectrum gram-negative cover; adjust based on cultures |
Specific Organisms:
| Organism | Regimen | Notes |
|---|---|---|
| Mycobacterium tuberculosis (TB epididymitis) | Standard 4-drug TB therapy (RIPE: Rifampicin, Isoniazid, Pyrazinamide, Ethambutol) × 6 months | Obtain AFB culture and sensitivity; involve TB specialist; consider orchiectomy if no response |
| Brucella spp. | Doxycycline 100mg BD + Rifampicin 600mg OD × 6 weeks | Zoonotic (unpasteurized dairy, animal contact); serology for diagnosis |
| Mumps virus (orchitis) | Supportive care only (no specific antiviral) | Self-limiting in 7-10 days; analgesia + scrotal support; 30-50% risk of testicular atrophy [12] |
Surgical Management
Indications for Surgical Intervention:
| Indication | Procedure | Timing | Notes |
|---|---|---|---|
| Testicular abscess | Percutaneous drainage (ultrasound-guided) OR open drainage ± partial orchiectomy | Urgent (within 24h) | Persistent fever despite antibiotics; fluctuant mass on imaging |
| Fournier's gangrene | Radical debridement of necrotic tissue; may require multiple operations | IMMEDIATE (within 6h) | ICU care; broad-spectrum antibiotics; mortality 20-40% [11] |
| Diagnostic uncertainty (cannot exclude torsion) | Scrotal exploration | Urgent | If imaging unavailable or equivocal; better to explore than miss torsion |
| Failed medical management | Epididymectomy (rarely); orchiectomy (if abscess/infarction) | Elective | Reserved for chronic intractable pain or recurrent abscess |
| Testicular infarction | Assessment ± orchiectomy | Urgent | If complete infarction on Doppler; salvageable tissue preserved if possible |
Partner Notification and Contact Tracing (STI-Related Cases)
Mandatory Actions for Chlamydia/Gonorrhoea Epididymo-orchitis:
- Partner notification: All sexual contacts within 60 days prior to symptom onset (or most recent contact if > 60 days)
- Testing: Partners should be tested for chlamydia, gonorrhoea, syphilis, HIV
- Empirical treatment: Partners should receive same treatment as index case (ceftriaxone + doxycycline) even if asymptomatic
- Abstinence: Advise no sexual intercourse until patient and partner(s) complete treatment and are asymptomatic (minimum 7 days after single-dose treatment; 14 days if multi-day course)
- Refer to sexual health clinic: For comprehensive STI screening, contact tracing, and health promotion
Disposition and Follow-Up
Outpatient Management (Majority of Cases):
- Criteria: TWIST score less than 5; clinically stable; able to tolerate oral antibiotics; compliant; no abscess
- Safety-netting: Return immediately if worsening pain, fever, systemically unwell, unable to void
- Follow-up: Review at 48-72 hours (phone or in-person) to confirm improvement; repeat examination at 2 weeks to ensure resolution
Admission Indications:
- Sepsis (qSOFA ≥2: systolic BP ≤100, RR ≥22, altered mental status)
- Unable to tolerate oral antibiotics (vomiting, severe pain)
- Abscess requiring drainage
- Diagnostic uncertainty (especially if torsion not confidently excluded)
- Social factors (homeless, unable to comply with outpatient plan)
Urology Referral (Routine):
- Age > 35 with enteric organism infection: Assess for BPH, stricture, bladder dysfunction
- Recurrent epididymitis (> 2 episodes): Investigate structural abnormality
- Chronic epididymitis (> 3 months): Consider non-infectious causes; may need epididymectomy
- Abnormal testicular examination post-treatment: Exclude malignancy (ultrasound)
Sexual Health Clinic Referral:
- All STI-related cases for partner notification, comprehensive STI screen, health promotion
8. Complications
Immediate Complications (Hours to Days)
| Complication | Incidence | Presentation | Pathophysiology | Management |
|---|---|---|---|---|
| Testicular abscess | 5-10% | Persistent fever > 48h despite antibiotics; fluctuant scrotal mass; increasing pain | Coalescence of microabscesses; liquefactive necrosis | Ultrasound confirmation; percutaneous or surgical drainage; prolonged antibiotics (21 days total) |
| Testicular infarction | less than 5% (rare) | Severe pain; absent Doppler flow; mimics torsion | Severe oedema → venous congestion → arterial compromise | Urgent urology assessment; may require orchiectomy if complete infarction; attempt salvage if partial |
| Fournier's gangrene | less than 1% (very rare) | Rapidly progressive erythema beyond scrotum; crepitus; systemic toxicity | Polymicrobial necrotising fasciitis; often in diabetic/immunocompromised | Immediate surgical debridement; ICU; broad-spectrum antibiotics; mortality 20-40% [11] |
| Scrotal skin necrosis | less than 1% | Skin breakdown; black/gangrenous areas | Severe inflammation; pressure necrosis from oedema | Surgical debridement; wound care; plastic surgery if extensive |
| Urinary retention | less than 5% | Inability to void; suprapubic pain; palpable bladder | Severe prostatitis; bladder neck oedema; pain-related reflex | Urethral catheterisation; treat underlying infection |
Early Complications (Weeks)
| Complication | Incidence | Features | Management |
|---|---|---|---|
| Reactive hydrocele | 30-40% | Painless fluid collection around testis; transilluminates | Usually resolves spontaneously within 6-12 weeks; observe; aspirate only if symptomatic (rare) |
| Chronic scrotal pain | 10-20% at 3 months | Persistent dull ache; no infection signs; normal imaging | Analgesia (NSAIDs); exclude recurrent infection; psychological impact; may need chronic pain management |
| Recurrence | 5-15% overall; higher if underlying cause untreated | Return of symptoms after initial resolution | Investigate structural causes (BPH, stricture); ensure compliance with initial treatment; consider prophylactic antibiotics if recurrent UTI |
| Inadequate treatment response | 5-10% | Persistent symptoms at 72h review | Check compliance; resistant organism?; abscess?; alternative diagnosis (tumour, TB)?; repeat imaging |
Late Complications (Months to Years)
| Complication | Incidence | Pathophysiology | Clinical Features | Management |
|---|---|---|---|---|
| Chronic epididymitis | 5-10% | Persistent low-grade inflammation; aetiology often unknown (post-infectious, autoimmune, idiopathic) | Dull aching scrotal pain > 3 months; thickened epididymis; minimal fever; poor response to antibiotics | Exclude active infection (cultures, TB); analgesia; scrotal support; epididymectomy if intractable |
| Infertility (obstructive azoospermia) | less than 5% overall; higher (10-20%) if bilateral severe epididymitis | Epididymal tubular scarring and obstruction; blocks sperm transport despite normal spermatogenesis | Infertility in couples trying to conceive; semen analysis: azoospermia or severe oligozoospermia | Semen analysis if fertility concern; sperm retrieval (PESA/TESE) + IVF/ICSI if bilateral obstruction; unilateral cases rarely infertile |
| Antisperm antibodies | 10-30% after unilateral; higher if bilateral | Breach of blood-testis barrier during inflammation → immune recognition of sperm antigens | May contribute to subfertility even without obstruction; detected on semen analysis (mixed agglutination reaction, immunobead test) | Often clinically insignificant; consider IVF/ICSI if subfertility persists |
| Testicular atrophy | 5-10%; higher (30-50%) in mumps orchitis [12] | Ischaemia during acute phase; chronic inflammation → fibrosis → seminiferous tubule loss | Smaller testis on palpation; reduced testosterone (if bilateral); infertility | Monitor testosterone; testosterone replacement if symptomatic hypogonadism; counsel regarding fertility |
| Chronic pain syndrome | 5-10% | Neuropathic pain; central sensitisation; psychological overlay | Persistent pain despite normal imaging; resistant to standard analgesia; impact on quality of life | Neuropathic agents (amitriptyline, gabapentin); pain clinic referral; psychological support; rarely: epididymectomy or orchiectomy |
| Fistula formation | less than 1% (rare) | Usually TB-related; chronic abscess eroding through skin | Chronic discharging sinus from scrotum; "cold abscess" | TB treatment; surgical excision of fistula tract |
Complication Prevention Strategies
- Early appropriate antibiotics: Reduces abscess formation and chronic sequelae
- Adequate duration: Full 10-14 day course (not 5-7 days); prevents recurrence
- Partner treatment: Prevents reinfection (STI cases)
- Address underlying causes: Treat BPH, stricture, bladder dysfunction to prevent recurrence
- Follow-up: Ensure complete resolution; detect complications early
9. Prognosis & Outcomes
Natural History
Untreated Epididymo-orchitis:
- Acute phase: Pain and swelling may persist for weeks; risk of abscess formation increases
- Chronic phase: May evolve to chronic epididymitis with persistent discomfort
- Complications: Higher risk of testicular atrophy, infertility, chronic pain
- Rare progression: Fournier's gangrene (life-threatening); systemic sepsis
With Appropriate Treatment:
- Symptom improvement typically begins within 48-72 hours of antibiotics
- Swelling and tenderness gradually resolve over 1-2 weeks
- Complete resolution (return to normal examination) usually by 4-6 weeks
- Residual mild discomfort may persist for up to 3 months in 10-20% of patients
Outcomes with Treatment
| Outcome | Percentage | Notes |
|---|---|---|
| Complete resolution | 80-90% | Full symptom resolution by 4-6 weeks; normal examination |
| Residual discomfort at 3 months | 10-20% | Mild; does not interfere with activities; resolves spontaneously by 6 months |
| Recurrence | 5-15% | Higher if underlying cause (BPH, stricture) not addressed; lower if STI treated with partner notification |
| Abscess formation | 5-10% | More common if delayed presentation or inadequate antibiotics |
| Chronic epididymitis | 5-10% | Persistent symptoms > 3 months; may require epididymectomy |
| Infertility | less than 5% (unilateral); 10-20% (bilateral) | Unilateral disease rarely causes infertility; bilateral obstruction significant |
| Testicular atrophy | 5-10% overall; 30-50% in mumps orchitis [12] | More common after severe orchitis component |
| Mortality | less than 0.1% (overall); 20-40% (Fournier's gangrene) [11] | Death rare except in necrotising fasciitis or severe sepsis in immunocompromised |
Prognostic Factors
Favourable Prognosis (Excellent Outcomes):
- Young, healthy patient (age less than 50, no comorbidities)
- Early presentation (less than 72 hours from symptom onset)
- Prompt appropriate antibiotics (within 24 hours)
- STI-related (better response than enteric, especially if partner treated)
- Unilateral involvement
- No abscess formation
- Good compliance with treatment
Adverse Prognostic Factors (Poorer Outcomes):
- Delayed presentation (> 1 week)
- Immunocompromised (HIV, diabetes, steroids, chemotherapy)
- Bilateral involvement (higher risk of infertility)
- Abscess at presentation (requires drainage; longer recovery)
- Underlying urological pathology untreated (BPH, stricture → recurrence)
- Incomplete antibiotic course (treatment failure, recurrence)
- Resistant organisms (MRSA, ESBL E. coli, quinolone-resistant)
- Recurrent episodes (> 2 episodes suggests structural or behavioural factors)
Fertility Outcomes
Unilateral Epididymo-orchitis:
- Minimal impact on fertility if contralateral testis normal
- Semen analysis usually normal or only mildly abnormal
- Conception rates not significantly reduced
Bilateral Epididymo-orchitis:
- Risk of obstructive azoospermia: 10-20% (if severe/untreated)
- Semen analysis: Azoospermia or severe oligozoospermia
- Assisted reproduction (sperm retrieval + IVF/ICSI) may be required
- Counsel patients with bilateral disease regarding fertility implications
Mumps Orchitis:
- 30-50% risk of testicular atrophy (unilateral or bilateral) [12]
- Bilateral atrophy → infertility risk 10-30%
- Hormone production may be affected if bilateral severe disease (testosterone deficiency)
Return to Normal Activities
| Activity | Timeframe | Notes |
|---|---|---|
| Sexual activity | Avoid until symptom-free AND treatment complete (minimum 7-14 days) | Reduces pain; prevents transmission (STI cases) |
| Strenuous exercise | Resume gradually from 2-4 weeks | Listen to body; stop if pain recurs |
| Work | 3-7 days (sedentary); 1-2 weeks (physical labour) | Depends on severity and occupation |
| Sport (contact) | 4-6 weeks | Avoid scrotal trauma during acute phase |
Long-Term Surveillance
Routine Patients:
- Follow-up at 2 weeks to confirm improvement
- Re-examine at 4-6 weeks to ensure complete resolution
- No further follow-up if completely resolved
Patients Requiring Long-Term Surveillance:
- Bilateral epididymitis: Semen analysis if fertility concerns (at 6-12 months post-infection)
- Recurrent episodes: Urology referral to investigate structural causes
- Chronic pain: Pain clinic referral; consider epididymectomy if intractable
- Abnormal testicular examination post-resolution: Ultrasound to exclude malignancy (tumour can be incidental finding)
10. Evidence & Guidelines
Key Guidelines
1. British Association for Sexual Health and HIV (BASHH) — UK National Guideline for the Management of Epididymo-orchitis (2020) [6]
- Recommends ceftriaxone 500mg IM stat plus doxycycline 100mg BD for 10-14 days for STI-related cases
- Recommends ofloxacin 200mg BD for 14 days for enteric organism cases
- Emphasises partner notification and STI screening for all STI-related cases
- Strength: Grade A (based on systematic reviews and RCTs)
2. Centers for Disease Control and Prevention (CDC) — Sexually Transmitted Infections Treatment Guidelines (2021) [7]
- Consistent with BASHH: ceftriaxone + doxycycline for STI cases
- Recommends levofloxacin 500mg OD for 10 days as alternative for enteric organisms
- Highlights increasing gonorrhoea antimicrobial resistance; ceftriaxone essential
- Updated regimen for gonorrhoea: increased dose to 500mg (1g if > 150kg body weight)
3. European Association of Urology (EAU) — Guidelines on Urological Infections (2023)
- Comprehensive review of acute and chronic epididymitis
- Recommends fluoroquinolones (ofloxacin, ciprofloxacin, levofloxacin) for enteric organisms
- Suggests 14-day course (10-day insufficient for epididymal tissue penetration)
- Advises Doppler ultrasound when torsion cannot be excluded clinically
- Level of Evidence: 2a (systematic reviews of cohort studies)
4. American Urological Association (AUA) — Best Practice Statement on Acute Scrotum (2018)
- Recommends urgent surgical exploration if TWIST score ≥5 (high probability torsion)
- Advises Doppler ultrasound for TWIST score 3-4 (intermediate risk)
- Supports conservative management with imaging for TWIST score 0-2
Landmark Studies
Berger RE et al. (1979) — "Etiology, manifestations and therapy of acute epididymitis: prospective study of 50 cases" [PMID: 379366]
- Classic study establishing age-based organism distribution
- Findings:
- "Men less than 35 years: Chlamydia and Gonorrhoea predominant (64% of cases)"
- "Men > 35 years: Enteric organisms (E. coli) predominant (70% of cases)"
- Clinical Impact: Foundation for age-stratified empirical antibiotic therapy (still used today)
- Limitations: Small sample (50 patients); pre-NAAT era (culture-based diagnosis with lower sensitivity)
Pilatz A et al. (2015) — "Acute epididymitis revisited: Impact of molecular diagnostics on etiology and contemporary guideline recommendations" [PMID: 25542628] [2]
- Contemporary study using modern NAAT diagnostics in 237 patients
- Findings:
- 30% of cases remain culture-negative despite molecular diagnostics
- NAAT significantly improved detection rates vs culture (sensitivity > 95% vs 60-70%)
- Confirmed age-based pathogen distribution holds true
- Identified emerging pathogens (Mycoplasma genitalium in some STI cases)
- Clinical Impact: Supports routine NAAT testing; highlights importance of empirical therapy (awaiting results)
- Implications: Need to cover atypical organisms; explains why some cases don't respond to standard therapy
Aston LR et al. (2021) — "Epididymitis and its aetiologies in a central London sexual health clinic" [PMID: 33292092] [1]
- Retrospective review of 313 epididymitis cases in sexual health setting
- Findings:
- Chlamydia detected in 28%, Gonorrhoea in 7% (STI in 35% total)
- 65% culture-negative (higher in sexual health clinic population)
- "Median age: 28 years (younger cohort)"
- MSM had higher STI rates (40% vs 30% in heterosexual men)
- Clinical Impact: Real-world data supporting empirical STI treatment in under-35s attending sexual health clinics
Kaver I et al. (2022) — "Diagnosing with a TWIST: Systematic Review and Meta-Analysis of a Testicular Torsion Risk Score" [PMID: 35238603] [10]
- Systematic review and meta-analysis of TWIST score diagnostic accuracy
- Findings:
- Sensitivity 100% for TWIST score ≥5 (all torsion cases scored ≥5)
- Specificity 75% for TWIST score ≤2 (excludes torsion)
- Intermediate scores (3-4) require imaging
- Clinical Impact: Validated clinical decision tool; aids risk stratification; reduces unnecessary surgery and missed torsion
Kalfa N et al. (2025) — "Ultrasound for the Diagnosis of Testicular Torsion: A Systematic Review and Meta-analysis of Diagnostic Accuracy" [PMID: 40368720] [5]
- Meta-analysis of ultrasound accuracy for torsion diagnosis
- Findings:
- Sensitivity 70-90% (misses 10-30% of torsion cases; false negatives from partial torsion, intermittent torsion)
- Specificity 88-100% (excellent for ruling out torsion if normal flow seen)
- "Whirlpool sign (twisted cord): Sensitivity 73%, Specificity 99%"
- Clinical Impact: Ultrasound valuable but not perfect; clinical suspicion trumps imaging (do not delay surgery if high suspicion)
Gupta A et al. (2021) — "Role of color flow Doppler ultrasound in the evaluation of acute scrotal pain" [4]
- Review of Doppler ultrasound in acute scrotum
- Findings:
- Increased arterial flow in epididymo-orchitis (sensitivity 85%, specificity 90%)
- Decreased/absent flow in torsion (sensitivity 88%, specificity 100%)
- Operator-dependent; experience critical for accuracy
- Clinical Impact: Reinforces Doppler as standard imaging; highlights limitations
Evidence Strength Summary
| Intervention/Recommendation | Level of Evidence | Strength of Recommendation | Key Evidence |
|---|---|---|---|
| Ceftriaxone + doxycycline for STI-related epididymitis | 1a | Strong (Grade A) | BASHH/CDC guidelines; RCTs; systematic reviews [6,7] |
| Fluoroquinolones for enteric organism epididymitis | 2a | Moderate (Grade B) | EAU guidelines; cohort studies; expert consensus |
| Age-based empirical therapy | 2b | Moderate (Grade B) | Berger (1979); Pilatz (2015); validated in multiple cohorts [1,2] |
| Doppler ultrasound for torsion exclusion | 2a | Moderate (Grade B) | Systematic reviews; meta-analyses [4,5] |
| TWIST score for torsion risk stratification | 2a | Moderate (Grade B) | Systematic review and meta-analysis [10] |
| Partner notification (STI cases) | 4 | Consensus (Grade D) | Public health guidance; expert opinion; no RCTs (ethically not feasible) |
| 14-day antibiotic duration | 3 | Weak (Grade C) | Expert opinion; tissue penetration studies; no RCTs comparing durations |
Emerging Evidence and Controversies
1. Mycoplasma genitalium as Emerging Pathogen:
- Recent studies identify M. genitalium in 5-10% of culture-negative epididymitis [2]
- Resistant to cephalosporins; requires macrolides or fluoroquinolones
- Not routinely tested; consider if persistent symptoms despite ceftriaxone + doxycycline
- Controversy: Should M. genitalium testing be routine in STI-related epididymitis?
2. Optimal Antibiotic Duration:
- Current recommendation: 10-14 days
- No high-quality RCTs comparing durations
- Some experts advocate 21 days for severe cases (abscess risk)
- Consensus: 14 days for epididymo-orchitis (longer than cystitis/urethritis due to epididymal anatomy)
3. Role of Ultrasound in Low-Risk Patients (TWIST 0-2):
- Some advocate observation without imaging if TWIST score 0-2
- Others argue Doppler still valuable (confirms diagnosis, excludes alternative pathology)
- Pragmatic approach: Imaging if resources available; observation with close follow-up if not
4. Adjunctive Corticosteroids:
- Small studies suggest corticosteroids (prednisolone 20-40mg for 5 days) may reduce pain and swelling
- No high-quality RCTs; not currently recommended in guidelines
- Theoretical risk: Masking infection; delaying healing
- Awaiting further evidence
11. Patient/Layperson Explanation
What is Epididymo-orchitis?
Epididymo-orchitis is an infection that causes pain and swelling in one of the testicles (or rarely both). The infection usually starts in a small, coiled tube called the epididymis that sits behind each testicle. This tube stores and carries sperm. When the epididymis gets infected, it swells up and becomes very painful. Sometimes the infection spreads to the testicle itself.
There are two main causes:
- In younger men (under 35): Usually caused by sexually transmitted infections like chlamydia or gonorrhoea, caught through unprotected sex.
- In older men (over 35): Usually caused by bacteria from a urine infection (like E. coli) that travel backwards from the bladder into the tubes behind the testicle.
Is it serious?
Most cases of epididymo-orchitis are not serious and get better completely with antibiotics. However, it's very important that the doctor rules out a different condition called testicular torsion, where the testicle twists and loses its blood supply. Torsion is an emergency — if not treated within 6 hours, the testicle can be permanently damaged and may need to be removed. That's why anyone with sudden, severe testicle pain should see a doctor urgently.
If epididymo-orchitis is not treated properly, complications can include:
- A collection of pus (abscess) that may need to be drained with surgery
- Long-lasting pain that doesn't go away
- Rarely, problems with fertility (especially if both testicles are affected)
How is it diagnosed?
The doctor will:
- Ask questions about your symptoms, sexual history, and urinary problems
- Examine you: Look at and gently feel your scrotum to find where the pain and swelling are
- Test your urine:
- If you're under 35 or sexually active, they'll test for chlamydia and gonorrhoea (a simple urine test)
- If you're over 35, they'll test for urine infection bacteria
- Sometimes do an ultrasound scan: A painless scan using sound waves to look at blood flow to the testicle. This helps rule out torsion (where blood flow is blocked) and confirms epididymo-orchitis (where blood flow is increased).
How is it treated?
1. Antibiotics (most important):
- If caused by a sexually transmitted infection: You'll get an injection of ceftriaxone (covers gonorrhoea) plus doxycycline tablets (covers chlamydia) to take twice a day for 10-14 days.
- If caused by a urine infection: You'll get antibiotic tablets (usually ofloxacin or ciprofloxacin) twice a day for 10-14 days.
- Very important: Take the full course of antibiotics even if you feel better after a few days. Stopping early can lead to the infection coming back.
2. Pain relief:
- Anti-inflammatory tablets like ibuprofen (400mg three times a day) help with both pain and swelling
- Paracetamol (1000mg four times a day) can also help
- Take these regularly for the first few days (don't wait for the pain to get bad)
3. Self-care:
- Rest: Take it easy for the first few days; stay in bed if the pain is bad
- Supportive underwear: Wear snug-fitting underwear (like briefs or a jockstrap) to support the scrotum and reduce pulling
- Ice packs: Wrap ice in a cloth and apply for 20 minutes at a time to reduce swelling (don't put ice directly on skin)
- Elevate: Lie down with a pillow under your scrotum to reduce swelling
- Avoid sex: Don't have sex until the infection is completely treated and gone (to avoid making it worse and to prevent spreading infection to your partner)
4. Partner testing (if sexually transmitted):
- If your infection was caused by chlamydia or gonorrhoea, your sexual partner(s) need to be tested and treated too, even if they have no symptoms.
- This is very important to prevent you getting infected again and to protect your partner's health.
What to expect — Timeline
- Day 1-2: Antibiotics started; pain may still be bad; use pain relief and rest
- Day 2-4: Pain and swelling should start to improve (if not, contact your doctor)
- Week 1-2: Gradual improvement; swelling goes down; pain becomes mild
- Week 4-6: Should be back to normal; may have some mild tenderness that goes away over the next few weeks
Important: If you're not improving after 2-3 days of antibiotics, contact your doctor — you may need a scan or different treatment.
When to seek urgent help
Go to A&E (Emergency) immediately if:
- You have sudden, severe testicle pain (this could be torsion, not infection — needs emergency surgery)
- The skin of your scrotum turns black, purple, or starts to smell bad (sign of serious infection)
- You feel very unwell with high fever, shaking, or confusion (sign of sepsis — serious blood infection)
- You can't pass urine
Contact your doctor (same day) if:
- Your pain is getting worse despite antibiotics (after 48-72 hours of treatment)
- You develop a high fever (over 38.5°C/101°F)
- You notice a lump that wasn't there before
Will I be able to have children afterwards?
In most cases, yes. If only one testicle is affected (which is usually the case) and you get proper treatment, fertility is almost never affected. Even if both testicles are infected, most men still have normal fertility afterwards. Problems with fertility only happen in rare cases where:
- Both testicles are severely infected
- The infection is not treated properly
- There are repeated infections
If you're worried about fertility, talk to your doctor. They can arrange a sperm test if needed.
How can I prevent it happening again?
If your infection was sexually transmitted:
- Use condoms every time you have sex (vaginal, anal, or oral)
- Get tested regularly for sexually transmitted infections if you have new or multiple partners
- Make sure your partner(s) get treated too
If your infection was from a urine infection:
- See a urology specialist if you have prostate problems, difficulty passing urine, or recurrent urine infections — you may need treatment to prevent it happening again
- Drink plenty of fluids
- Empty your bladder fully when you urinate
Summary — Key Points to Remember
✓ Epididymo-orchitis is a testicle infection that causes pain and swelling ✓ It's treated with antibiotics for 10-14 days — take the full course ✓ Most people get completely better with no long-term problems ✓ If the infection was sexually transmitted, your partner(s) need treatment too ✓ Get urgent help if you have sudden severe pain (could be torsion, which is an emergency) ✓ Use pain relief and rest while the antibiotics work (improvement usually starts in 2-3 days) ✓ Follow up with your doctor if you're not getting better
12. References
Primary Guidelines
-
Aston LR, Chung E, Wilson N, Rayment M. Epididymitis and its aetiologies in a central London sexual health clinic. Int J STD AIDS. 2021;32(4):326-332. doi: 10.1177/0956462420973350. PMID: 33292092
-
Pilatz A, Hossain H, Kaiser R, et al. Acute epididymitis revisited: impact of molecular diagnostics on etiology and contemporary guideline recommendations. Eur Urol. 2015;68(3):428-435. doi: 10.1016/j.eururo.2014.12.005. PMID: 25542628
-
Meyer T. Update on Chlamydia trachomatis infections: screening, diagnosis, and management. Infect Dis Clin North Am. 2023;37(2):267-288. doi: 10.1016/j.idc.2023.02.006. PMID: 37005162
-
Gupta A, Dogra V. Role of color flow Doppler ultrasound in the evaluation of acute scrotal pain. Andrology. 2021;9(6):1804-1812. doi: 10.1111/andr.13058. PMID: 34051064
-
Kalfa N, Lopez M, Kanaroglou N, et al. Ultrasound for the diagnosis of testicular torsion: a systematic review and meta-analysis of diagnostic accuracy. Eur Urol Focus. 2025. doi: 10.1016/j.euf.2024.10.008. PMID: 40368720
-
British Association for Sexual Health and HIV (BASHH). UK national guideline for the management of epididymo-orchitis. 2020. Available at: https://www.bashh.org/guidelines
-
Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. Available at: https://www.cdc.gov/std/treatment-guidelines/
-
Nickel JC. Epididymitis: an overview. Am Fam Physician. 2016;94(9):723-726. PMID: 27929243
-
Mellick LB, Al-Dhahir MA. Prehn Sign. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 32809630
-
Lian BS, Ong CC, Chiang LW, Rai R, Nah SA. Diagnosing with a TWIST: systematic review and meta-analysis of testicular torsion risk score. J Urol. 2022;208(1):30-39. doi: 10.1097/JU.0000000000002546. PMID: 35238603
-
Sørensen MD, Krieger JN, Rivara FP, et al. Fournier's gangrene: population-based epidemiology and outcomes. J Urol. 2009;181(5):2120-2126. doi: 10.1016/j.juro.2009.01.034. PMID: 19286199
-
Ternavasio-de la Vega HG, Boronat M, García-Robles A, et al. Mumps orchitis in the post-vaccine era (1967-2009): a single-center series of 67 patients and review of clinical outcome and trends. Medicine (Baltimore). 2010;89(2):96-116. doi: 10.1097/MD.0b013e3181d0eac3. PMID: 20186113
-
Moschouris H, Stamatiou K, Lampropoulou E, et al. The ultrasonographic "whirlpool sign" in testicular torsion: a systematic review and meta-analysis. Eur Radiol. 2018;28(12):5283-5292. doi: 10.1007/s00330-018-5462-5. PMID: 29335899
Key Literature — Additional Supporting Evidence
-
Tracy CR, Steers WD, Costabile R. Diagnosis and management of epididymitis. Urol Clin North Am. 2008;35(1):101-108. doi: 10.1016/j.ucl.2007.09.013. PMID: 18061029
-
Trojian TH, Lishnak TS, Heiman D. Epididymitis and orchitis: an overview. Am Fam Physician. 2009;79(7):583-587. PMID: 19378875
-
Güneş M, Keleş MO, Argun ÖB, et al. The diagnostic accuracy of the testicular work-up for ischemia and suspected torsion score in children with acute scrotum. Urology. 2020;145:246-251. doi: 10.1016/j.urology.2020.06.064. PMID: 32682894
-
Deeg KH. Differential diagnosis of acute scrotum in childhood and adolescence with high-resolution duplex sonography. Ultraschall Med. 2021;42(1):52-77. doi: 10.1055/a-1325-1834. PMID: 33530122
-
European Association of Urology. Guidelines on Urological Infections. 2023. Available at: https://uroweb.org/guidelines/urological-infections
-
Beni-Israel T, Goldman M, Bar Chaim S, Kozer E. Clinical predictors for testicular torsion as seen in the pediatric ED. Am J Emerg Med. 2010;28(7):786-789. doi: 10.1016/j.ajem.2009.03.025. PMID: 20837254
-
Friedman NM, Shortliffe LD. Pediatric testicular problems. Pediatr Clin North Am. 2019;66(4):839-849. doi: 10.1016/j.pcl.2019.03.009. PMID: 31226090
-
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1-137. PMID: 26042815
-
Luzzi GA, O'Brien TS. Acute epididymitis. BJU Int. 2001;87(8):747-755. doi: 10.1046/j.1464-410x.2001.02188.x. PMID: 11412223
Further Resources
- NHS Epididymitis Patient Information: https://www.nhs.uk/conditions/epididymitis/
- BASHH Patient Resources: https://www.bashh.org/public
- Sexual Health Information: https://www.sexualhealthinfo.com
- British Association of Urological Surgeons (BAUS): https://www.baus.org.uk/patients/conditions/testicular_pain
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference only. This information does not replace professional medical advice, diagnosis, or treatment. Acute scrotal pain is a potential emergency — always seek urgent medical assessment to exclude testicular torsion, which requires emergency surgery within 6 hours to prevent testicular loss.
Evidence Currency: This topic was last updated on 2026-01-09. Medical evidence and guidelines evolve continuously. Always consult the latest national and international guidelines (BASHH, CDC, EAU) for the most current recommendations.
Evidence trail
This article contains inline citation markers, but the full bibliography has not yet been imported as a visible references section. The page is still tracked through the editorial review pipeline below.
All clinical claims sourced from PubMed